Products
Latest News
-
π°
Un-Audited 3rd Quarterly (Q3) Financial Statements 3 May, 2026
-
π°
UN-AUDITED HALF YEARLY (Q2) FINANCIAL STATEMENTS 31 December, 2025
-
π°
Notice of The Extra-Ordinary General Meeting (EGM), December 23, 2025 27 November, 2025
-
π°
Dividend Distribution Policy 24 November, 2025
-
π°
Notice of the 42nd Annual General Meeting 24 November, 2025
-
π°
Price Sensitive Information Regarding Un-audited 1st Quarter Financial Statements, September 30, 2025 24 November, 2025
-
π°
42 AGM Notice | Orion Infusion Ltd 13 November, 2025
-
π°
41 AGM Notice | Orion Infusion Ltd 9 December, 2024
-
π°
Dividend Distribution Policy 23 November, 2024
-
π°
Price Sensitive Information 20 November, 2024
-
π°
UN-AUDITED FIRST QUARTERLY (Q1) FINANCIAL STATEMENTS 20 November, 2024
-
π°
PSI Q3 Orion Infusion Limited 30 April, 2024
-
π°
PSI Orion Infusion Limited (For the year ended on June 30, 2023) 25 November, 2023
-
π°
PRICE SENSITIVE INFORMATION REGARDING UN-AUDITED 1ST QUARTER FINANCIAL STATEMENTS 25 November, 2023
-
π°
Proxy Form 28 November, 2021
-
π°
PSI Q1 2021 16 November, 2021
-
π°
PSI and AGM, 2021 14 November, 2021
-
π°
Price Sensitive Information 1 July, 2021
-
π°
AGM and EGM Meeting Link-2020 19 December, 2020
-
π°
NOTICE OF AN EXTRA-ORDINARY GENERAL MEETING 5 December, 2019
-
π°
PSI_Press release_Q1_2019_OIL 13 November, 2019
-
π°
EGM Notice_OIL 4 November, 2019
-
π°
Price Sensitive Information 24 October, 2019
-
π°
UN-AUDITED HALF YEARLY (Q2) FINNANCIAL STATEMENTS 3 February, 2019
-
π°
UN-AUDITED 1st QUARTERLY FINNANCIAL STATEMENTS 15 November, 2018
-
π°
UN-AUDITED THIRD QUARTERLY (Q3) FINNANCIAL STATEMENTS 2 May, 2017
-
π°
Share Bazaar Awareness 18 February, 2017
-
π°
Share Bazaar Awareness 16 February, 2017
-
π°
UN-AUDITED HALF YEARLY (Q2) FINNANCIAL STATEMENTS 1 February, 2017
-
π°
Un-Audited 3rd Quarterly (Q3) Financial Statements 3 May, 2026
-
π°
UN-AUDITED HALF YEARLY (Q2) FINANCIAL STATEMENTS 31 December, 2025
-
π°
Notice of The Extra-Ordinary General Meeting (EGM), December 23, 2025 27 November, 2025
-
π°
Dividend Distribution Policy 24 November, 2025
-
π°
Notice of the 42nd Annual General Meeting 24 November, 2025
-
π°
Price Sensitive Information Regarding Un-audited 1st Quarter Financial Statements, September 30, 2025 24 November, 2025
-
π°
42 AGM Notice | Orion Infusion Ltd 13 November, 2025
-
π°
41 AGM Notice | Orion Infusion Ltd 9 December, 2024
-
π°
Dividend Distribution Policy 23 November, 2024
-
π°
Price Sensitive Information 20 November, 2024
-
π°
UN-AUDITED FIRST QUARTERLY (Q1) FINANCIAL STATEMENTS 20 November, 2024
-
π°
PSI Q3 Orion Infusion Limited 30 April, 2024
-
π°
PSI Orion Infusion Limited (For the year ended on June 30, 2023) 25 November, 2023
-
π°
PRICE SENSITIVE INFORMATION REGARDING UN-AUDITED 1ST QUARTER FINANCIAL STATEMENTS 25 November, 2023
-
π°
Proxy Form 28 November, 2021
-
π°
PSI Q1 2021 16 November, 2021
-
π°
PSI and AGM, 2021 14 November, 2021
-
π°
Price Sensitive Information 1 July, 2021
-
π°
AGM and EGM Meeting Link-2020 19 December, 2020
-
π°
NOTICE OF AN EXTRA-ORDINARY GENERAL MEETING 5 December, 2019
-
π°
PSI_Press release_Q1_2019_OIL 13 November, 2019
-
π°
EGM Notice_OIL 4 November, 2019
-
π°
Price Sensitive Information 24 October, 2019
-
π°
UN-AUDITED HALF YEARLY (Q2) FINNANCIAL STATEMENTS 3 February, 2019
-
π°
UN-AUDITED 1st QUARTERLY FINNANCIAL STATEMENTS 15 November, 2018
-
π°
UN-AUDITED THIRD QUARTERLY (Q3) FINNANCIAL STATEMENTS 2 May, 2017
-
π°
Share Bazaar Awareness 18 February, 2017
-
π°
Share Bazaar Awareness 16 February, 2017
-
π°
UN-AUDITED HALF YEARLY (Q2) FINNANCIAL STATEMENTS 1 February, 2017
Latest Reports
-
π
September 30 ,2012 (1st Quarter) Quarterly Report 2012
-
π
Financial Statements (Un-audited) for the Period Ended 31 March 2025 (Third Quarter) Quarterly Report 2025
-
π
24 th Annual Report Annual Report 05-07
-
π
Financial Statements (Un-audited) for the Period Ended 31 March 2019 (Third Quarter) Half Yearly Report 2019, 2020, 2021
-
π
Half Yearly Report 2011
-
π
Financial Statements(UnAudited) at 31st March 2015 Quarterly Report 2015
-
π
Un-Audited Half Yearly (Q2) Financial Statements Half Yearly Report 2024
-
π
Condensed Interim Financial Statements (Un-audited) as at and for Three Month Period Ended 30 September 2020 Orion Infusion Limited (First Quarter) Quarterly Report 2020
-
π
Proxy From-2012 Annual Report 11-12
-
π
Financal Statements As On 31 December-2015 Half Yearly Report 2015
-
π
Auditor's Report 2020 Annual Report 2020
-
π
Annual Financial Report 2017-18 Annual Report 2017-18
-
π
Financial Statements (Un-Addit) As 31st March-2017 Quarterly Report 2017
-
π
3rd Quarter - 2012 - 13 Final Quarterly Report 2013
-
π
Annual Report 2010-2011 Annual Report 10-11
-
π
Auditor's Report 1990 Audit Report 1990-2004
-
π
Half yearly 2010 Half Yearly Report 2010
-
π
Financial Statements (Un-audited) for the Period Ended 31 March 2019 (Third Quarter) Quarterly Report 2019
-
π
Annual Report 2009-2010 Annual Report 09-10
-
π
31st September-2015 First Quarter Quarterly Report 2015
-
π
Financial Statements December 31, 202 Half Yearly Report 2024
-
π
Financial Statements (Unaudited) as on 31st December 2016 (Half Yearly) Half Yearly Report 2016
-
π
Annual Financial Report 2023-24 Annual Report 2023-24
-
π
Annual Report 2021-22 Annual Report 2021-22
-
π
Financial Statements (Un-audited) as on 30th September 2017 (First Quarter) Quarterly Report 2017
-
π
Statement of Financial Position (Un Audited) Quarterly Report 2013
-
π
Half Yearly Report Half Yearly Report 2012
-
π
Condensed Interim Financial Statements (Un-audited) as at and for Three Month Period Ended 30 September 2019 Quarterly Report 2019
-
π
Financial Statements (Un-Audited) As on 31 March-2016 Quarterly Report 2016
-
π
Financial Statements (Unaudited) As At And For The Period Ended December 31, 2025 Half Yearly Report 2025
-
π
Financial Statements (Unaudited) as on 31st December 2017 (Half Yearly) Half Yearly Report 2017
-
π
Auditor's Report 2024 Annual Report 2023-24
-
π
Financial Statements (Un-audited) for the Period Ended 31 March 2018 (Third Quarter) Quarterly Report 2018
-
π
Annual Report Contents Annual Report 2014
-
π
3rd Quarterly Financial Statements (Un Audited) As at 31 march-2014 Quarterly Report 2014
-
π
Financial Statements (unaudited) As At And For The Period Ended March 31, 2026 Quarterly Report 2026
-
π
Un-Audited Half Yearly (Q2) Financial Statements Half Yearly Report 2023
-
π
As at and for Nine Month Period Ended 31 March 2020, Orion Infusion Limited (Third Quarter) Quarterly Report 2020
-
π
Half Year Financlal Statement (Unaudited) As At 31 December-2013 Half Yearly Report 2013
-
π
Un-Audited 1st Quarterly Financial Statements at 30th September 2016 Quarterly Report 2016
-
π
31 March2011 3rd Quarter Quarterly Report 2011
-
π
Auditor's Report 2009 Annual Report 08-09
-
π
September 30, 2023 (First Quarter) Quarterly Report 2023
-
π
Condensed Interim Financial Statements (Un-audited) as at and for Six Month Period Ended 31st December 2018 Half Yearly Report 2018
-
π
Auditor's Report and Financial Statements 2025 Annual Report 2024-25
-
π
Annual Report 2019 Part-1 Annual Report 2019
-
π
Un-Audited 1st Quarterly Financial Statements 2018 Quarterly Report 2018
-
π
Financeal Statements (Unaudited) at 30th September-2014 Quarterly Report 2014
-
π
Financial Position (Un-audited) as at September 30, 2021 Quarterly Report 2021
-
π
Finacial Statement31 December-2014 Half Yearly Half Yearly Report 2014
-
π
Annual Report 2022-23 Annual Report 2022-23
-
π
Finacial Statement (Un-Audited)As On 30th September 2016 Quarterly Report 2016
-
π
Annual Report 2019 Part-2 Annual Report 2019
-
π
Financial Statements (1st Quarter) - September 30, 2024 Quarterly Report 2024
-
π
Un-Audited 3rd Quarterly (Q3) Financial Statements Quarterly Report 2025
-
π
Financial Report 2006-2007 Annual Report 05-07
-
π
Financial Statements (Un-audited) for the Period Ended December 31, 2020 (Half Yearly) Half Yearly Report 2019, 2020, 2021
-
π
Condensed Interim Financial Statements (Un-audited)as at and for Nine Month Period Ended March 31, 2021 Quarterly Report 2020
-
π
29th Annual Report-2012 Annual Report 11-12
-
π
General Information Annual Report 10-11
-
π
Our Vision Mission & Values Annual Report 09-10
-
π
Director's Report 2020 Annual Report 2020
-
π
Message From the Chairman Annual Report 07-08
-
π
Board Of Directors Annual Report 2014
-
π
Auditor's Report 1991 Audit Report 1990-2004
-
π
Financial Statements December 31, 2023 Half Yearly Report 2023
-
π
Corporate Social Responsibility(CSR) Annual Report 2014
-
π
Auditor's Report 1992 Audit Report 1990-2004
-
π
Annual Report 2019 Part-3 Annual Report 2019
-
π
Financial Statements (Unaudited) For September 30, 2025 (First Quarter) Quarterly Report 2025
-
π
Quality Policy Annual Report 05-07
-
π
Six Month Period Ended December 31, 2021 (Half Yearly) Half Yearly Report 2019, 2020, 2021
-
π
25 Annual Report Annual Report 07-08
-
π
Board of Directors Annual Report 10-11
-
π
Board of Directors Annual Report 09-10
-
π
AGM-2013 Proxy Form Annual Report 2013
-
π
Annual General Meeating-2013 Annual Report 2014
-
π
Auditor's Report 1993 Audit Report 1990-2004
-
π
Auditor's Report 2007 Annual Report 05-07
-
π
Annual Report 2019 Part-4 Annual Report 2019
-
π
Auditor's Report 2008 Annual Report 07-08
-
π
Un-Audited 3.d Quarterly (Q3)-March 31, 2024 Quarterly Report 2024
-
π
Annual Report 2024-25 Annual Report 2024-25
-
π
Chairman Profile Annual Report 10-11
-
π
Management Committee Annual Report 09-10
-
π
Company Secretary & Management Committee Annual Report 10-11
-
π
Auditor's Report 2006 Annual Report 05-07
-
π
Company at a Glance Annual Report 09-10
-
π
Annexure To The director's Report Annual Report 2014
-
π
Auditor's Report 1994 Audit Report 1990-2004
-
π
Annual Report 2019 Part-5 Annual Report 2019
-
π
Quality Policy & ISO 9001:2000 Annual Report 09-10
-
π
Auditor's Report 2005 Annual Report 05-07
-
π
Annexure To The director's Report Annual Report 2014
-
π
Auditor's Report 1995 Audit Report 1990-2004
-
π
Annual Report 2019 Part-6 Annual Report 2019
-
π
Auditor's Report 1996 Audit Report 1990-2004
-
π
Company at a Glance Annual Report 10-11
-
π
Human Resource Development Annual Report 09-10
-
π
Notes To The Financial Statements Annual Report 2014
-
π
Strategic Business Units Annual Report 10-11
-
π
Annual General Meeating-2013-14 Annual Report 2014
-
π
Auditor's Report 1997 Audit Report 1990-2004
-
π
Annul General Meeting-2009 Annual Report 09-10
-
π
Product List Annual Report 09-10
-
π
Our Vision, Our Mission Goals & Values Annual Report 10-11
-
π
5 Years At A Glance Annual Report 09-10
-
π
Financial Report 2012-2013 Annual Report 2013
-
π
Company History Annual Report 10-11
-
π
Financial Report 2012-2013 Annual Report 2013
-
π
Quality Policy Annual Report 10-11
-
π
Message From The Chairman Annual Report 09-10
-
π
Human Resources Development Annual Report 10-11
-
π
Financial Report 2012-2013 Annual Report 2013
-
π
Financial Report 2009-2010 Annual Report 09-10
-
π
Financial Report 2012-2013 Annual Report 2013
-
π
Brand Performance Annual Report 10-11
-
π
Financial Report 2009-2010 & Proxy From Annual Report 09-10
-
π
Company at a Glance Annual Report 2013
-
π
Annual General Meeting 2010 & Annual Marketing & Sales Conference Annual Report 10-11
-
π
Product List Annual Report 10-11
-
π
Auditor's Report 1998 Audit Report 1990-2004
-
π
5 Years At A Glance Annual Report 10-11
-
π
Auditor's Report 1999 Audit Report 1990-2004
-
π
Quality Policy Annual Report 2013
-
π
Auditor's Report 2000 Audit Report 1990-2004
-
π
Financial Report 2010-2011 Annual Report 10-11
-
π
Message From the Chairman Annual Report 2013
-
π
Auditor's Report 2001 Audit Report 1990-2004
-
π
Annexure To the Director's Report Annual Report 2013
-
π
Notes of the Financial Statements For The year Ended June30,2011 Annual Report 10-11
-
π
Message From The Chairman Annual Report 10-11
-
π
Auditor's Report 2002 Audit Report 1990-2004
-
π
Directorsβ Report To the Shareholders Annual Report 10-11
-
π
Auditor's Report 2003 Audit Report 1990-2004
-
π
Auditor's Report 2004 Audit Report 1990-2004
-
π
September 30 ,2012 (1st Quarter) Report of Annual Report Β» Audit Report 1990-2004
-
π
Financial Statements (Un-audited) for the Period Ended 31 March 2025 (Third Quarter) Report of Annual Report Β» Audit Report 1990-2004
-
π
24 th Annual Report Report of Annual Report Β» Audit Report 1990-2004
-
π
Financial Statements (Un-audited) for the Period Ended 31 March 2019 (Third Quarter) Report of Annual Report Β» Audit Report 1990-2004
-
π
Report of Annual Report Β» Audit Report 1990-2004
-
π
Financial Statements(UnAudited) at 31st March 2015 Report of Annual Report Β» Audit Report 1990-2004
-
π
Un-Audited Half Yearly (Q2) Financial Statements Report of Annual Report Β» Audit Report 1990-2004
-
π
Condensed Interim Financial Statements (Un-audited) as at and for Three Month Period Ended 30 September 2020 Orion Infusion Limited (First Quarter) Report of Annual Report Β» Audit Report 1990-2004
-
π
Proxy From-2012 Report of Annual Report Β» Audit Report 1990-2004
-
π
Financal Statements As On 31 December-2015 Report of Annual Report Β» Audit Report 1990-2004
-
π
Auditor's Report 2020 Report of Annual Report Β» Audit Report 1990-2004
-
π
Annual Financial Report 2017-18 Report of Annual Report Β» Audit Report 1990-2004
-
π
Financial Statements (Un-Addit) As 31st March-2017 Report of Annual Report Β» Audit Report 1990-2004
-
π
3rd Quarter - 2012 - 13 Final Report of Annual Report Β» Audit Report 1990-2004
-
π
Annual Report 2010-2011 Report of Annual Report Β» Audit Report 1990-2004
-
π
Auditor's Report 1990 Report of Annual Report Β» Audit Report 1990-2004
-
π
Half yearly 2010 Report of Annual Report Β» Audit Report 1990-2004
-
π
Financial Statements (Un-audited) for the Period Ended 31 March 2019 (Third Quarter) Report of Annual Report Β» Audit Report 1990-2004
-
π
Annual Report 2009-2010 Report of Annual Report Β» Audit Report 1990-2004
-
π
31st September-2015 First Quarter Report of Annual Report Β» Audit Report 1990-2004
-
π
Financial Statements December 31, 202 Report of Annual Report Β» Audit Report 1990-2004
-
π
Financial Statements (Unaudited) as on 31st December 2016 (Half Yearly) Report of Annual Report Β» Audit Report 1990-2004
-
π
Annual Financial Report 2023-24 Report of Annual Report Β» Audit Report 1990-2004
-
π
Annual Report 2021-22 Report of Annual Report Β» Audit Report 1990-2004
-
π
Financial Statements (Un-audited) as on 30th September 2017 (First Quarter) Report of Annual Report Β» Audit Report 1990-2004
-
π
Statement of Financial Position (Un Audited) Report of Annual Report Β» Audit Report 1990-2004
-
π
Half Yearly Report Report of Annual Report Β» Audit Report 1990-2004
-
π
Condensed Interim Financial Statements (Un-audited) as at and for Three Month Period Ended 30 September 2019 Report of Annual Report Β» Audit Report 1990-2004
-
π
Financial Statements (Un-Audited) As on 31 March-2016 Report of Annual Report Β» Audit Report 1990-2004
-
π
Financial Statements (Unaudited) As At And For The Period Ended December 31, 2025 Report of Annual Report Β» Audit Report 1990-2004
-
π
Financial Statements (Unaudited) as on 31st December 2017 (Half Yearly) Report of Annual Report Β» Audit Report 1990-2004
-
π
Auditor's Report 2024 Report of Annual Report Β» Audit Report 1990-2004
-
π
Financial Statements (Un-audited) for the Period Ended 31 March 2018 (Third Quarter) Report of Annual Report Β» Audit Report 1990-2004
-
π
Annual Report Contents Report of Annual Report Β» Audit Report 1990-2004
-
π
3rd Quarterly Financial Statements (Un Audited) As at 31 march-2014 Report of Annual Report Β» Audit Report 1990-2004
-
π
Financial Statements (unaudited) As At And For The Period Ended March 31, 2026 Report of Annual Report Β» Audit Report 1990-2004
-
π
Un-Audited Half Yearly (Q2) Financial Statements Report of Annual Report Β» Audit Report 1990-2004
-
π
As at and for Nine Month Period Ended 31 March 2020, Orion Infusion Limited (Third Quarter) Report of Annual Report Β» Audit Report 1990-2004
-
π
Half Year Financlal Statement (Unaudited) As At 31 December-2013 Report of Annual Report Β» Audit Report 1990-2004
-
π
Un-Audited 1st Quarterly Financial Statements at 30th September 2016 Report of Annual Report Β» Audit Report 1990-2004
-
π
31 March2011 3rd Quarter Report of Annual Report Β» Audit Report 1990-2004
-
π
Auditor's Report 2009 Report of Annual Report Β» Audit Report 1990-2004
-
π
September 30, 2023 (First Quarter) Report of Annual Report Β» Audit Report 1990-2004
-
π
Condensed Interim Financial Statements (Un-audited) as at and for Six Month Period Ended 31st December 2018 Report of Annual Report Β» Audit Report 1990-2004
-
π
Auditor's Report and Financial Statements 2025 Report of Annual Report Β» Audit Report 1990-2004
-
π
Annual Report 2019 Part-1 Report of Annual Report Β» Audit Report 1990-2004
-
π
Un-Audited 1st Quarterly Financial Statements 2018 Report of Annual Report Β» Audit Report 1990-2004
-
π
Financeal Statements (Unaudited) at 30th September-2014 Report of Annual Report Β» Audit Report 1990-2004
-
π
Financial Position (Un-audited) as at September 30, 2021 Report of Annual Report Β» Audit Report 1990-2004
-
π
Finacial Statement31 December-2014 Half Yearly Report of Annual Report Β» Audit Report 1990-2004
-
π
Annual Report 2022-23 Report of Annual Report Β» Audit Report 1990-2004
-
π
Finacial Statement (Un-Audited)As On 30th September 2016 Report of Annual Report Β» Audit Report 1990-2004
-
π
Annual Report 2019 Part-2 Report of Annual Report Β» Audit Report 1990-2004
-
π
Financial Statements (1st Quarter) - September 30, 2024 Report of Annual Report Β» Audit Report 1990-2004
-
π
Un-Audited 3rd Quarterly (Q3) Financial Statements Report of Annual Report Β» Audit Report 1990-2004
-
π
Financial Report 2006-2007 Report of Annual Report Β» Audit Report 1990-2004
-
π
Financial Statements (Un-audited) for the Period Ended December 31, 2020 (Half Yearly) Report of Annual Report Β» Audit Report 1990-2004
-
π
Condensed Interim Financial Statements (Un-audited)as at and for Nine Month Period Ended March 31, 2021 Report of Annual Report Β» Audit Report 1990-2004
-
π
29th Annual Report-2012 Report of Annual Report Β» Audit Report 1990-2004
-
π
General Information Report of Annual Report Β» Audit Report 1990-2004
-
π
Our Vision Mission & Values Report of Annual Report Β» Audit Report 1990-2004
-
π
Director's Report 2020 Report of Annual Report Β» Audit Report 1990-2004
-
π
Message From the Chairman Report of Annual Report Β» Audit Report 1990-2004
-
π
Board Of Directors Report of Annual Report Β» Audit Report 1990-2004
-
π
Auditor's Report 1991 Report of Annual Report Β» Audit Report 1990-2004
-
π
Financial Statements December 31, 2023 Report of Annual Report Β» Audit Report 1990-2004
-
π
Corporate Social Responsibility(CSR) Report of Annual Report Β» Audit Report 1990-2004
-
π
Auditor's Report 1992 Report of Annual Report Β» Audit Report 1990-2004
-
π
Annual Report 2019 Part-3 Report of Annual Report Β» Audit Report 1990-2004
-
π
Financial Statements (Unaudited) For September 30, 2025 (First Quarter) Report of Annual Report Β» Audit Report 1990-2004
-
π
Quality Policy Report of Annual Report Β» Audit Report 1990-2004
-
π
Six Month Period Ended December 31, 2021 (Half Yearly) Report of Annual Report Β» Audit Report 1990-2004
-
π
25 Annual Report Report of Annual Report Β» Audit Report 1990-2004
-
π
Board of Directors Report of Annual Report Β» Audit Report 1990-2004
-
π
Board of Directors Report of Annual Report Β» Audit Report 1990-2004
-
π
AGM-2013 Proxy Form Report of Annual Report Β» Audit Report 1990-2004
-
π
Annual General Meeating-2013 Report of Annual Report Β» Audit Report 1990-2004
-
π
Auditor's Report 1993 Report of Annual Report Β» Audit Report 1990-2004
-
π
Auditor's Report 2007 Report of Annual Report Β» Audit Report 1990-2004
-
π
Annual Report 2019 Part-4 Report of Annual Report Β» Audit Report 1990-2004
-
π
Auditor's Report 2008 Report of Annual Report Β» Audit Report 1990-2004
-
π
Un-Audited 3.d Quarterly (Q3)-March 31, 2024 Report of Annual Report Β» Audit Report 1990-2004
-
π
Annual Report 2024-25 Report of Annual Report Β» Audit Report 1990-2004
-
π
Chairman Profile Report of Annual Report Β» Audit Report 1990-2004
-
π
Management Committee Report of Annual Report Β» Audit Report 1990-2004
-
π
Company Secretary & Management Committee Report of Annual Report Β» Audit Report 1990-2004
-
π
Auditor's Report 2006 Report of Annual Report Β» Audit Report 1990-2004
-
π
Company at a Glance Report of Annual Report Β» Audit Report 1990-2004
-
π
Annexure To The director's Report Report of Annual Report Β» Audit Report 1990-2004
-
π
Auditor's Report 1994 Report of Annual Report Β» Audit Report 1990-2004
-
π
Annual Report 2019 Part-5 Report of Annual Report Β» Audit Report 1990-2004
-
π
Quality Policy & ISO 9001:2000 Report of Annual Report Β» Audit Report 1990-2004
-
π
Auditor's Report 2005 Report of Annual Report Β» Audit Report 1990-2004
-
π
Annexure To The director's Report Report of Annual Report Β» Audit Report 1990-2004
-
π
Auditor's Report 1995 Report of Annual Report Β» Audit Report 1990-2004
-
π
Annual Report 2019 Part-6 Report of Annual Report Β» Audit Report 1990-2004
-
π
Auditor's Report 1996 Report of Annual Report Β» Audit Report 1990-2004
-
π
Company at a Glance Report of Annual Report Β» Audit Report 1990-2004
-
π
Human Resource Development Report of Annual Report Β» Audit Report 1990-2004
-
π
Notes To The Financial Statements Report of Annual Report Β» Audit Report 1990-2004
-
π
Strategic Business Units Report of Annual Report Β» Audit Report 1990-2004
-
π
Annual General Meeating-2013-14 Report of Annual Report Β» Audit Report 1990-2004
-
π
Auditor's Report 1997 Report of Annual Report Β» Audit Report 1990-2004
-
π
Annul General Meeting-2009 Report of Annual Report Β» Audit Report 1990-2004
-
π
Product List Report of Annual Report Β» Audit Report 1990-2004
-
π
Our Vision, Our Mission Goals & Values Report of Annual Report Β» Audit Report 1990-2004
-
π
5 Years At A Glance Report of Annual Report Β» Audit Report 1990-2004
-
π
Financial Report 2012-2013 Report of Annual Report Β» Audit Report 1990-2004
-
π
Company History Report of Annual Report Β» Audit Report 1990-2004
-
π
Financial Report 2012-2013 Report of Annual Report Β» Audit Report 1990-2004
-
π
Quality Policy Report of Annual Report Β» Audit Report 1990-2004
-
π
Message From The Chairman Report of Annual Report Β» Audit Report 1990-2004
-
π
Human Resources Development Report of Annual Report Β» Audit Report 1990-2004
-
π
Financial Report 2012-2013 Report of Annual Report Β» Audit Report 1990-2004
-
π
Financial Report 2009-2010 Report of Annual Report Β» Audit Report 1990-2004
-
π
Financial Report 2012-2013 Report of Annual Report Β» Audit Report 1990-2004
-
π
Brand Performance Report of Annual Report Β» Audit Report 1990-2004
-
π
Financial Report 2009-2010 & Proxy From Report of Annual Report Β» Audit Report 1990-2004
-
π
Company at a Glance Report of Annual Report Β» Audit Report 1990-2004
-
π
Annual General Meeting 2010 & Annual Marketing & Sales Conference Report of Annual Report Β» Audit Report 1990-2004
-
π
Product List Report of Annual Report Β» Audit Report 1990-2004
-
π
Auditor's Report 1998 Report of Annual Report Β» Audit Report 1990-2004
-
π
5 Years At A Glance Report of Annual Report Β» Audit Report 1990-2004
-
π
Auditor's Report 1999 Report of Annual Report Β» Audit Report 1990-2004
-
π
Quality Policy Report of Annual Report Β» Audit Report 1990-2004
-
π
Auditor's Report 2000 Report of Annual Report Β» Audit Report 1990-2004
-
π
Financial Report 2010-2011 Report of Annual Report Β» Audit Report 1990-2004
-
π
Message From the Chairman Report of Annual Report Β» Audit Report 1990-2004
-
π
Auditor's Report 2001 Report of Annual Report Β» Audit Report 1990-2004
-
π
Annexure To the Director's Report Report of Annual Report Β» Audit Report 1990-2004
-
π
Notes of the Financial Statements For The year Ended June30,2011 Report of Annual Report Β» Audit Report 1990-2004
-
π
Message From The Chairman Report of Annual Report Β» Audit Report 1990-2004
-
π
Auditor's Report 2002 Report of Annual Report Β» Audit Report 1990-2004
-
π
Directorsβ Report To the Shareholders Report of Annual Report Β» Audit Report 1990-2004
-
π
Auditor's Report 2003 Report of Annual Report Β» Audit Report 1990-2004
-
π
Auditor's Report 2004 Report of Annual Report Β» Audit Report 1990-2004
Maprocin

Maprocin
GENERAL INFORMATION :Maprocin (Ciprofloxacin) is a fluorinated 4-quinolone antimicrobial agent. Ciprofloxacin represents important therapeutic advancement for broad-spectrum antimicrobial activity and is effective after administration.
Brand Name : Maprocin
Generic Name : Ciprofloxacin
Official Specification : USP
Therapeutic Class : Fluoroquinolone antibiotic
Dosage form : Tablet, Suspension, IV
|
Brand |
Strength |
Pack |
MRP (Tk.) |
|
Maprocin 500 Tab |
500 mg |
3x10's |
421.5 |
|
Maprocin 750 Tab |
750 mg |
2x10's |
361.2 |
|
Maprocin Suspension |
250mg/5ml |
60 ml |
90.34 |
|
Maprocin IV 0.2% |
200mg/100mlΒ |
100 ml |
70.26 |
|
Maprocin IV DS 0.4% |
400mg/100mlΒ |
100 ml |
130.49 |
INDICATIONS :
Maprocin-500 & Maprocin-750 Tab: Severe and Complicated- Bone & joint infections, Lower respiratory tract
infections, Skin & skin structure infections, Urinary tract infections, Surgical prophylaxis (60-90 minutes
before procedure).
Other Indications: Urethral and cervical gonococcal infections and other sexually
transmitted
diseases.
Maprocin Susp: Typhoid fever, Infectious diarrhea, Bone & joint infections, Lower
respiratory
tract infections, Gastro-intestinal infections.
Maprocin IV : Pneumonia, Infected pleurisy, Lung abscess, Bronchiectasis, Acute
exacerbation
of
chronic bronchitis, Salpingitis, Endometritis, Pelvic inflammatory disease, Enteric fever, Infective
diarrhea,
Otitis media, Sinusitis, Mastoiditis, Otitis externa, Peritonitis, Intra-abdominal infections, Abscesses,
Cholangitis, Cholecystitis, Empyema of gall bladder, Infected ulcers, Wound infections, Abscess, Cellulitis,
Acute and chronic Osteomyelitis, Septic arthritis, Acute and chronic pyelo-nephritis, Prostatitis, cystitis,
Epididymitis, and chronic, complicated or recurrent UTI.
|
Indications |
Dose |
Duration |
|
Lower respiratory tract infections |
500 β 750 mg, 12 hourly |
7β14 days |
|
Typhoid fever |
500 mg, 12 hourly |
10 days |
|
Infectious diarrhea |
500 mg, 12 hourly |
5-7 days |
|
Bone &Β joint infections |
500β750 mg, 12 hourly |
4 β 6 wks |
|
Skin & skin structure infections |
500 mg, 12 hourly |
7β14 days |
Children (above 1 year): 10-30 mg/kg/day depending on the severity of infections, administered in two divided dose.
Maprocin IV:
Adults:
Infusion Rate: 25-50 drops/min
Infusion period: 30-60 minutes.
Duration: 7 days
Per day: 2 times.
Dosage Range: 200mg (100ml bag)
Children:
The doses of Ciprofloxacin I.V. (MAPROCIN INJECTION) should be 5-10mg/kg/day in two divided doses. (If a child is 10 kg, then dose is 100mg and is given by 50mg & 50mg in a day).